Skip to content
Clinical Trials – home
Sponsor

Faron Pharmaceuticals Oy

Finland Joukahaisenkatu 6, 20520 Turku, Finland

About the sponsor

Faron Pharmaceuticals Oy focuses on hematologic malignancies, with clinical research centered on malignant disorders of the blood and bone marrow.

  • Acute Myeloid Leukemia
  • Chronic Myelomonocytic Leukemia
  • Myelodysplastic Syndrome

The sponsor’s research activity in this area is directed toward treatment settings where standard of care remains a key component of therapy.

About Specializations

Faron Pharmaceuticals Oy runs clinical trials in conditions such as Myelodysplastic syndrome, Acute myeloid leukaemia, Chronic myelomonocytic leukaemia, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Myelodysplastic syndrome

Not yet recruiting

Study of Bexmarilimab with Azacitidine versus Placebo with Azacitidine in Treatment‑Naïve Higher‑Risk Myelodysplastic Syndrome Patients

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bexmarilimab
  • Sponsor:Faron Pharmaceuticals Oy

Acute myeloid leukaemia+2

Not recruiting

Study of Bexmarilimab Combined with Standard Treatment for Patients with Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia

InvestigationalNo placebo
Countries:FinlandFinland
  • Participants:18–64 years · 65+ years
  • Substances:Bexmarilimab
  • Sponsor:Faron Pharmaceuticals Oy

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.